KRYSCommon stockNASDAQ
KRYS Common stock
This is the ticker-level security page. The issuer is Krystal Biotech, Inc..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$290.5M
Net income TTM
$89.2M
Total assets
Not available
Total debt
Not available
Total equity
Not available
Profit margin
30.7%
ROE
Not available
ROA
Not available
Latest issuer financial snapshot: 2024-12-31